Cargando…

Heterogeneity and evolution of tumour immune microenvironment in metastatic gastroesophageal adenocarcinoma

BACKGROUND: Tumour immune microenvironment heterogeneity is prevalent in numerous cancers and can negatively impact immunotherapy response. Immune heterogeneity and evolution in gastroesophageal adenocarcinoma (GEA) have not been studied in the past. METHODS: Together with a multi-region sampling of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Wei, Ye, Liu-Fang, Bao, Hua, Hu, Ming-Tao, Han, Ming, Tang, Hai-Meng, Ren, Chao, Wu, Xue, Shao, Yang, Wang, Feng-Hua, Zhou, Zhi-Wei, Li, Yu-Hong, Xu, Rui-Hua, Wang, De-Shen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Nature Singapore 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587966/ https://www.ncbi.nlm.nih.gov/pubmed/35904677 http://dx.doi.org/10.1007/s10120-022-01324-7

Ejemplares similares

Hypoxia and its impact on the tumour microenvironment of gastroesophageal cancers
por: King, Ross, et al.
Publicado: (2021)

Effectiveness and Safety of Apatinib in Patients with Advanced or Metastatic Adenocarcinoma of Stomach or Gastroesophageal Junction: A Prospective Observation Study
por: Shen, Bo, et al.
Publicado: (2020)

Genomic temporal heterogeneity of circulating tumour DNA in unresectable metastatic colorectal cancer under first-line treatment
por: Wang, Feng, et al.
Publicado: (2022)

Association Between Spatial Heterogeneity Within Nonmetastatic Gastroesophageal Adenocarcinomas and Survival
por: Chao, Joseph, et al.
Publicado: (2020)

Impact of Sites of Metastatic Dissemination on Survival in Advanced Gastroesophageal Adenocarcinoma
por: Wang, Xin, et al.
Publicado: (2022)

Comprehensive Analysis of N6-Methyladenosine (m(6)A) RNA Methylation Regulators and Tumour Microenvironment Cell Infiltration Involving Prognosis and Immunotherapy in Gastroesophageal Adenocarcinomas
por: Liu, Duanrui, et al.
Publicado: (2022)

Treatment for metastatic adenocarcinoma of the stomach and gastroesophageal junction: 2020
por: Hsu, Andrew, et al.
Publicado: (2020)

Genomic landscape and evolution of arm aneuploidy in lung adenocarcinoma
por: Gao, Beili, et al.
Publicado: (2021)

Immune microenvironment analysis and novel biomarkers of early-stage lung adenocarcinoma evolution
por: Liu, Jun, et al.
Publicado: (2023)

Evolving Management Strategies for Metastatic Esophageal and Gastroesophageal Junction Adenocarcinoma
por: Das, Satya, et al.
Publicado: (2018)

Midesophageal Metastatic Disease After Treatment of Gastroesophageal Junction Adenocarcinoma
por: Brotherton, Tim, et al.
Publicado: (2022)

Evaluation of Event-Free Survival Surrogating Overall Survival as the Endpoint in Neoadjuvant Clinical Trials of Gastroesophageal Adenocarcinoma
por: Liu, Hua, et al.
Publicado: (2022)

Irinotecan, docetaxel and oxaliplatin combination in metastatic gastric or gastroesophageal junction adenocarcinoma
por: Di Lauro, L, et al.
Publicado: (2007)

Editorial: Tumour microenvironment heterogeneity in hematological malignancies
por: Deaglio, Silvia, et al.
Publicado: (2023)

Understanding heterogeneous tumor microenvironment in metastatic melanoma
por: Yan, Yiyi, et al.
Publicado: (2019)

Longitudinal monitoring of circulating tumour DNA improves prognostication and relapse detection in gastroesophageal adenocarcinoma
por: Openshaw, Mark R., et al.
Publicado: (2020)

Genomic landscape of metastatic lung adenocarcinomas from large-scale clinical sequencing
por: Li, Dingbiao, et al.
Publicado: (2021)

Combination of apatinib mesylate and second-line chemotherapy for treating gastroesophageal junction adenocarcinoma
por: Lu, Bin, et al.
Publicado: (2019)

Adjuvant chemoradiotherapy vs adjuvant chemotherapy in locally advanced Siewert type II/III adenocarcinoma of gastroesophageal junction after D2/R0 resection
por: Kang, Wen-Zhe, et al.
Publicado: (2022)

Dual HER2 blockade with lapatinib and trastuzumab in combination with chemotherapy in metastatic gastroesophageal adenocarcinoma
por: Cheong, E. Von, et al.
Publicado: (2021)

Combination of clinical, radiomic, and “delta” radiomic features in survival prediction of metastatic gastroesophageal adenocarcinoma
por: Krishna, Satheesh, et al.
Publicado: (2023)

Genomic and epigenomic profiles distinguish pulmonary enteric adenocarcinoma from lung metastatic colorectal cancer
por: Zuo, Ying, et al.
Publicado: (2022)

Phase 1 multicenter, dose-expansion study of ARX788 as monotherapy in HER2-positive advanced gastric and gastroesophageal junction adenocarcinoma
por: Zhang, Yang, et al.
Publicado: (2022)

Identification of Sensitivity Predictors of Neoadjuvant Chemotherapy for the Treatment of Adenocarcinoma of Gastroesophageal Junction
por: Li, Shoumiao, et al.
Publicado: (2017)

Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU)
por: Hosen, S. M. Zahid, et al.
Publicado: (2022)

Multi‐omics analysis of intra‐tumoural and inter‐tumoural heterogeneity in pancreatic ductal adenocarcinoma
por: Liu, Xiaoqian, et al.
Publicado: (2022)

Single‐cell profiling reveals tumour cell heterogeneity accompanying a pre‐malignant and immunosuppressive microenvironment in gastric adenocarcinoma
por: Ge, Jie, et al.
Publicado: (2023)

Gastrointestinal Goblet Cell Adenocarcinomas Harbor Distinctive Clinicopathological, Immune, and Genomic Landscape
por: Lin, Dong-Liang, et al.
Publicado: (2021)

Therapeutic Targeting of the Tumour Microenvironment in Metastatic Colorectal Cancer
por: Dmello, Rhynelle S., et al.
Publicado: (2021)

Editorial: Triple-negative breast cancer: Heterogeneity, tumor microenvironment and targeted therapy
por: Deng, Xiyun, et al.
Publicado: (2022)

Elevated peripheral blood neutrophil-to-lymphocyte ratio is associated with an immunosuppressive tumour microenvironment and decreased benefit of PD-1 antibody in advanced gastric cancer
por: Ruan, Dan-Yun, et al.
Publicado: (2021)

A real-world evidence of efficacy of palliative gastrectomy plus chemotherapy in metastatic gastric cancer patients
por: Yang, Lu-Ping, et al.
Publicado: (2019)

Analysis of prognostic genes in the tumor microenvironment of lung adenocarcinoma
por: Xu, Zhan-yu, et al.
Publicado: (2020)

Complete response of a metastatic gastroesophageal adenocarcinoma on irinotecan-based chemotherapy in a dialysis patient
por: Verwimp, J, et al.
Publicado: (2010)

Phase II study of epirubicin, oxaliplatin and docetaxel combination in metastatic gastric or gastroesophageal junction adenocarcinoma
por: Di Lauro, Luigi, et al.
Publicado: (2009)

Gastroesophageal junction adenocarcinoma metastasizing to gingiva
por: Masamatti, Smita S, et al.
Publicado: (2013)

Customization of therapy for gastroesophageal adenocarcinoma patients
por: Mizrak Kaya, Dilsa, et al.
Publicado: (2018)

Epidemiology of Gastroesophageal Junction Adenocarcinoma in Korea
por: Kim, Jin-Jo
Publicado: (2018)

Incidence of Microscopically Positive Proximal Margins in Adenocarcinoma of the Gastroesophageal Junction
por: Gao, Fei, et al.
Publicado: (2014)

Genomic Heterogeneity and Clonal Evolution in Gastroesophageal Junction Cancer Revealed by Single Cell DNA Sequencing
por: Duan, Qingke, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_43ng7c22r6e8mna64m5jr7kk49